0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cholesterol, statins and cancer.

      Clinical and Experimental Pharmacology & Physiology
      Animals, Case-Control Studies, Cell Cycle, Cholesterol, physiology, Homeostasis, drug effects, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, therapeutic use, Membrane Microdomains, Neoplasms, enzymology, metabolism, prevention & control, Proto-Oncogene Proteins c-akt, Risk, Signal Transduction, Sterol Regulatory Element Binding Proteins

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          1. The link between cholesterol and cardiovascular disease is well-established. Emerging evidence is now forging a tantalizing link between cholesterol and cancer. 2. Results from a number of case-control studies have indicated that the commonly prescribed cholesterol-lowering drugs, the statins, may reduce the risk of certain cancers, although this area certainly remains controversial. 3. Herein, the recent literature examining statins and cancer is reviewed briefly and the relationship between a key cholesterol homeostatic pathway and signalling pathways that are involved in carcinogenesis is discussed. In particular, how the sterol-regulatory element binding protein, Akt and Hedgehog pathways may converge in cancer is reviewed.

          Related collections

          Author and article information

          Comments

          Comment on this article